DistantNews
Support us
๐Ÿ‡ฎ๐Ÿ‡ฉ Indonesia /Economy & Trade

Two Companies Debut on Indonesia Stock Exchange After Strong IPOs

From Tempo · () Indonesian

Translated from Indonesian, summarized and contextualized by DistantNews.

At a glance

News Named sources New plan
  • Two companies, PT Niramas Utama Tbk (JELI) and PT Nitrasanata Dharma Tbk (JECX), debuted on the Indonesia Stock Exchange through IPOs.
  • JELI, known for its Inaco brand, raised Rp239.4 billion, while JECX, operator of Jakarta Eye Center, raised Rp609 billion.
  • Both IPOs saw strong investor demand, indicating continued activity and investor interest in Indonesia's capital market.

Indonesia's capital market saw renewed activity as two companies successfully launched their Initial Public Offerings (IPOs) on the Indonesia Stock Exchange (IDX) on Tuesday, July 7, 2026. PT Niramas Utama Tbk, widely recognized for its "Inaco" food and beverage products, and PT Nitrasanata Dharma Tbk, the operator of Jakarta Eye Center (JEC) hospitals and clinics, marked their stock market debuts.

PT Niramas Utama Tbk, trading under the ticker JELI, offered 266 million new shares, representing 21.01 percent of its enlarged capital. The shares opened at Rp900, and the offering was met with significant investor enthusiasm, particularly in the retail segment, which was oversubscribed 273.37 times. The company successfully raised Rp239.4 billion before issuance costs.

Adhi S. Lukman, President Director of JELI, hailed the listing as a "major milestone" and the "beginning of a new phase" for the company. He expressed gratitude to investors, regulators, and business partners for their support throughout the IPO process.

The listing of our shares on the Indonesia Stock Exchange marks an important milestone in the company's journey and the beginning of a new phase as a public company.

โ€” Adhi S. LukmanPresident Director of PT Niramas Utama Tbk (JELI) described the significance of the company's stock market debut.

Similarly, PT Nitrasanata Dharma Tbk (JECX) offered 487.98 million shares, or 15 percent of its enlarged capital, at Rp1,250 per share. This IPO generated Rp609 billion, with the centralized allotment portion oversubscribed 62.5 times. President Director Johan Hutauruk stated that the proceeds would strengthen the company's capital structure and support JEC's long-term expansion, while reaffirming its commitment to patient-centered eye care.

The successful IPOs of JELI and JECX, despite operating in distinct sectors, consumer goods and healthcare, underscore the continued vibrancy and investor confidence in Indonesia's capital market.

Through this IPO, the company hopes to strengthen its capital structure and support JEC's future growth while continuing to uphold the spirit of 'care with experience' by providing patient-oriented services backed by JEC's expertise and experience in eye healthcare.

โ€” Johan HutaurukPresident Director of PT Nitrasanata Dharma Tbk (JECX) explained how the IPO proceeds would be utilized.
DistantNews Editorial

Originally published by Tempo in Indonesian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.